Western blot analysis of GATA3 expression in (1) SH-SY5Y cell lysate; (2) Jurkat cell lysate.
| A03650 | |
|
|
|
| ¥37,309.00 | |
|
|
|
|
|
|
| Ask us a question | |
| Specificity | This product is specific to GATA3 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human GATA3 |
| Species Reactivity | Human |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||||||
|
|||||||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
Western blot analysis of GATA3 expression in (1) SH-SY5Y cell lysate; (2) Jurkat cell lysate.
| Target Background | Transcriptional activator which binds to the enhancer of the T-cell receptor alpha and delta genes. Binds to the consensus sequence 5'-AGATAG-3'. |
| Synonyms | GATA-binding factor 3; GATA3; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
